The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Actonel Combi 35mg + 500mg film-coated tablets



Theramex Ireland LimitedPA22668/001/001

Main Information

Trade NameActonel Combi 35mg + 500mg film-coated tablets
Active SubstancesRisedronate sodium
Calcium carbonate
Dosage FormFilm-coated tablet
Licence HolderTheramex Ireland Limited
Licence NumberPA22668/001/001

Group Information

ATC CodeM05BB Bisphosphonates, combinations
M05BB04 risedronic acid, calcium and colecalciferol, sequential

Status

License statusWithdrawn
Withdrawn Date17/01/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back